Metabolic Syndrome: Integrative Care for Insulin Resistance, Fatty Liver and High Triglycerides

Is low magnesium linked with metabolic syndrome? And does vitamin D help?

Low magnesium intake is linked with metabolic syndrome: in a 2025 meta-analysis by Kim and Je in Nutrients (27 publications, 95,933 people), those with the highest magnesium intake had a 21% lower risk of developing metabolic syndrome in long-term (prospective) studies [5], and an earlier meta-analysis found 17% lower odds for every extra 100 mg of dietary magnesium a day [6]. These are observational links, not proof that low magnesium causes the syndrome, and trials are still needed [5].

• Vitamin D, stated plainly: lower blood vitamin D goes with metabolic syndrome in snapshot (cross-sectional) studies, but not in the long-term studies analysed in a dose-response meta-analysis [7].
• Vitamin D trials: in a 2025 meta-analysis of 25 trials in people with obesity-related metabolic syndrome, vitamin D supplements did not significantly change triglycerides, cholesterol, blood sugar, insulin resistance or waist size [8]; a 2024 meta-analysis of 12 trials found the same, with small benefits only in some subgroups [9]. In the D2d trial of 2,423 adults with prediabetes, vitamin D did not significantly lower new diabetes [10].
• Magnesium testing: a blood magnesium test does not reliably reflect how much magnesium the body holds, according to the US National Institutes of Health [11], so we judge magnesium with diet, history and symptoms.
• What this means for you: eat magnesium-rich foods, have vitamin D checked and corrected if low, and work on insulin resistance, waist size and triglycerides directly, because these are the findings linked with higher heart and diabetes risk [1][2].

What is metabolic syndrome? The 5 criteria

Metabolic syndrome is a cluster of linked risk factors that together raise the risk of heart disease, stroke and type 2 diabetes. It is diagnosed when 3 or more of 5 findings are present; no single finding is required, according to the 2009 joint statement of six international bodies, including the International Diabetes Federation and the American Heart Association [1]:

• Other names: insulin resistance syndrome, according to the US National Heart, Lung, and Blood Institute (NHLBI) [13], and syndrome X.
• How common: about 1 in 3 adults in the US [13]; 30% of adults in India, rising from 13% at 18 to 29 years to 50% at 50 to 59, and higher in cities (32%) than in villages (22%) [3]; worldwide, 45% of adults have a larger waist and 29% high triglycerides [4].
• Waist in India: the Indian consensus for Asian Indians advises seeking medical help with a waist of 90 cm or more in men or 80 cm or more in women [12].

What are the symptoms of metabolic syndrome?

Most people have no symptoms: the NHS says you may not have any symptoms of metabolic syndrome, and it is usually found through a blood test or check-up [14]. Insulin resistance itself usually causes no symptoms either, according to the US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [15].

• What you may notice: a larger waist or fat around the tummy, and raised blood pressure, sugar or triglycerides on routine tests [14][1].
• What it can lead to: heart disease and type 2 diabetes, and possibly fatty liver disease, osteoarthritis, gout and some cancers, and it can sometimes affect fertility, according to the NHS [14].

What causes metabolic syndrome?

The exact cause is not known, but it is linked to insulin resistance and, often, to extra fat around the abdomen, according to the NHS [14].

• Risk factors: obesity, a diet high in saturated fat, low physical activity, South Asian or Hispanic background, smoking, drinking a lot of alcohol and older age [14].
• Insulin resistance: the body does not respond to insulin as it should; it is linked with overweight or a large waist, not being physically active, sleep apnoea and taking some medicines over time, such as glucocorticoid steroids, according to NIDDK [15].
• South Asians: a WHO expert consultation found that Asian people have higher diabetes and heart risk at a lower body mass index (BMI) than European people [16]; the Indian consensus puts overweight at a BMI of 23 and obesity at 25 or more [12].
• Processed food: in large US cohorts, more ultra-processed food was linked with a higher risk of type 2 diabetes [17].
• Smoking and sleep: the NHS advises stopping smoking [14], and NIDDK lists sleep apnoea among conditions linked with insulin resistance and getting enough sleep as part of healthy living [15]; see our Insomnia & Sleep Problems page.

What is insulin resistance?

Insulin resistance means the body does not respond to insulin the way it should, which can raise blood sugar and contribute to weight gain, according to the US National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [15]. It usually causes no symptoms, and formal insulin resistance tests are mainly used in research [15].

• Linked conditions: NIDDK lists PCOS, sleep apnoea and fatty liver among conditions linked with insulin resistance [15].
• At Cure4Pain: we estimate it with fasting glucose, fasting insulin and HOMA-IR, and follow the same person over time.

How is metabolic syndrome different from type 2 diabetes, prediabetes and PCOS?

Metabolic syndrome is a cluster of risk factors, while type 2 diabetes is a disease diagnosed by blood sugar tests; metabolic syndrome raises the risk of type 2 diabetes, according to the NHS [14]. For HbA1c ranges, prediabetes and diabetes medicines, see our Type 2 Diabetes page.

• Prediabetes: raised fasting sugar is one of the 5 criteria [1]; many people with prediabetes also meet the criteria: 53% of people with impaired glucose tolerance in the US Diabetes Prevention Program did [18].
• PCOS: in a 2019 meta-analysis, women with polycystic ovary syndrome had about 3.4 times the odds of metabolic syndrome, linked mainly with body weight [19].
• Obesity: a person can meet the criteria without obesity, and obesity alone is not metabolic syndrome; the criteria use waist size, not weight or BMI [1].

Why does metabolic syndrome matter?

Metabolic syndrome roughly doubles the risk of heart disease: in a meta-analysis in the Journal of the American College of Cardiology (Mottillo and colleagues, 87 studies, 951,083 people), metabolic syndrome was linked with 2.35 times the risk of cardiovascular disease, 2.27 times the risk of stroke and 1.58 times the risk of death from any cause, also in people without diabetes [2].

• Fatty liver: liver fat with at least 1 of 5 cardiometabolic risk factors is now called metabolic dysfunction-associated steatotic liver disease (MASLD), the new name for non-alcoholic fatty liver disease [20].
• Uric acid and gout: in prospective studies, people with the highest uric acid had about 1.7 times the risk of developing metabolic syndrome, and higher uric acid also went with fatty liver [21]; the NHS lists gout among the possible effects of metabolic syndrome [14].

How is metabolic syndrome diagnosed?

A doctor asks about your medical history, checks your BMI, waist and blood pressure, and arranges blood tests for blood sugar and blood fats, sometimes after fasting for up to 12 hours, according to the NHS [14]; 3 or more of the 5 criteria confirm it [1][22].

How does Cure4Pain manage metabolic syndrome?

Cure4Pain manages metabolic syndrome with the same base plan as type 2 diabetes: tests first, a low-carbohydrate home-cooked diet with meal timing, exercise for lean muscle, nutrient correction and a careful review of medicines, under clinical guidance from Team Cure4Pain and in coordination with your existing consulting physician.

• Who we see: adults and young people aged 16 and over with metabolic syndrome, insulin resistance with normal blood sugar, fatty liver, high triglycerides, the metabolic side of PCOS, and high uric acid or gout. We refer children to a paediatrician and pregnant women to their obstetrician.

The plan includes:

1. Tests first: our type 2 diabetes blood panel plus uric acid, a liver ultrasound or liver stiffness scan, waist measurement, body composition, thyroid tests and cortisol (see below).
2. Diet and meal timing: low carbohydrate, home cooked, no processed foods, jowar and millets in place of wheat, fruit and raw foods limited, and three meals a day with intermittent fasting where it is safe for you (see below).
3. Exercise for lean muscle: resistance training, 5,000 to 7,000 steps a day, walking after meals, yoga and Buteyko breathing; the aim is lean muscle and a smaller waist, which we measure (see below).
4. Nutrients: vitamin D corrected with standard supplement doses in most cases, magnesium, omega-3 and, where needed, berberine or inositol, within official limits (see below).
5. Medicines: statins, blood-pressure medicines and metformin reviewed by Dr Krushal Pabari, case by case (see below).
6. Specialists from the start: for heart, liver or kidney complications, we involve the relevant specialists from the first visit, alongside Dr Krushal Pabari.
7. Follow-up: blood tests every 3 months, with monitoring continued for life.

Our plan combines approaches tested separately in research; the combination is clinic practice, individual results vary, and further studies are needed.

What tests does Cure4Pain do for metabolic syndrome?

We start with the blood panel we use for type 2 diabetes, about 100 measures, and add tests for the liver, uric acid, body composition and hormones; the panel is our clinic protocol, not a guideline requirement.

• Blood sugar and insulin: HbA1c, fasting glucose and fasting insulin, with HOMA-IR when needed; NIDDK notes that formal insulin resistance tests are mainly used in research [15], so we use them to follow one person over time.
• Blood fats, liver, kidney and uric acid: lipid profile, liver and kidney function and uric acid [21].
• Fatty liver: a liver ultrasound or a liver stiffness scan (transient elastography) (see the fatty liver section).
• Waist and body composition: waist size is one of the 5 criteria [1]; body composition shows muscle and fat.
• Thyroid and cortisol: thyroid tests (see our Hypothyroidism page), and cortisol because Cushing’s syndrome, most often caused by high doses of steroid medicines, adds body fat on the neck, upper back, chest and tummy, according to the NHS [23].
• Nutrients and the rest of the panel: vitamin D with PTH, vitamin B12, iron studies, complete blood count, hsCRP and ANA by the IFA method; a positive ANA alone does not mean you have an autoimmune disease.

In India, the panel is available at a lower cost through our patient portal, with home collection across India. Outside India, the tests are done at a laboratory near you and reviewed with you in the consultation.

What is the best diet for metabolic syndrome? Low-carb, home-cooked, millets in place of wheat

Lifestyle change is the first treatment, according to the NHS [14], and in the US Diabetes Prevention Program, intensive lifestyle change (7% weight loss and 150 minutes of exercise a week) lowered new cases of metabolic syndrome by 41% over about 3 years, compared with 17% for metformin, each against placebo [18]. At Cure4Pain, the diet is low-carbohydrate and home cooked, with jowar and millets in place of wheat, the same as on our Type 2 Diabetes page, and planned separately for vegetarians and non-vegetarians.

• Low carbohydrate: in a controlled feeding study of 16 adults with obesity and metabolic syndrome, each person ate low-, moderate- and high-carbohydrate diets for 4 weeks each, in random order, with weight kept steady; 9 no longer met the criteria after the low-carbohydrate diet, compared with 1 after the high-carbohydrate diet [24]. The study was small, short and part-funded by dairy organisations.
• Mediterranean-style eating: in a meta-analysis of 50 studies (534,906 people), it was linked with lower risk of metabolic syndrome and improved waist, HDL, triglycerides, blood pressure and blood sugar [25].
• Jowar and millets in place of wheat: a 2021 meta-analysis found millets have a low glycaemic index and lowered fasting and after-meal blood sugar [26]. Replacing wheat is our clinic practice; we found no study showing that wheat itself harms people without coeliac disease.
• Fruit: as clinic practice, we limit fruit to once or twice a week. The research differs: the NHS advises eating more fruit, vegetables and wholegrains [14], and in large US cohorts, whole fruit was linked with a lower risk of type 2 diabetes and fruit juice with a higher risk [27]. Fruit juice is best avoided.
• Raw foods and cruciferous vegetables: as clinic practice, we advise cooked rather than raw vegetables and, as an observational clinic practice, generally suggest limiting cruciferous (Brassica) vegetables such as cabbage and cauliflower; research has not shown that either affects metabolic syndrome, and these vegetables are a source of fibre.
• Three meals and intermittent fasting: in a 12-week study of 19 people with metabolic syndrome, most already on statins or blood-pressure medicines, eating within a 10-hour window lowered weight, waist, blood pressure and LDL cholesterol; the study had no control group [28]. Fasting with diabetes medicines is planned only with Dr Krushal Pabari.
• Fatty liver and alcohol: the American Association for the Study of Liver Diseases (AASLD) advises assessing alcohol regularly and stopping it completely when the liver shows significant scarring [29].

How much exercise helps metabolic syndrome? Lean muscle, steps and walking

A 2026 umbrella review of 12 meta-analyses found that exercise improved all 5 criteria of metabolic syndrome [30]. The NHS advises at least 150 minutes of moderate to intense exercise a week and avoiding long periods of sitting [14].

• Interval training: in 23 randomised trials (1,374 people with metabolic syndrome), it lowered waist by about 4 cm and systolic blood pressure by about 6 mmHg, with moderate continuous exercise working similarly [31].
• Aerobic and resistance training: a 2018 meta-analysis of people with metabolic syndrome without diabetes found aerobic exercise improved waist, triglycerides, HDL, blood sugar and blood pressure, while resistance training alone showed no significant effect, possibly because there were few trials [32]; a 2026 umbrella review found combined aerobic and resistance training improved blood sugar, triglycerides and blood pressure more than either alone [30].
• Why lean muscle: in 13,644 US adults, each 10% increase in relative muscle mass was linked with 11% lower insulin resistance (HOMA-IR); this is an association, not proof of cause [33]. Resistance training for lean muscle is our clinic practice.
• Steps: a 2025 meta-analysis in The Lancet Public Health linked about 7,000 steps a day with meaningful health benefits, including a lower risk of type 2 diabetes [34].
• Yoga: a 2016 meta-analysis of 7 trials found yoga improved waist and systolic blood pressure, but not the other criteria, and the authors could make no recommendation for or against it [35]. We use yoga as part of the plan; further studies are needed.
• Buteyko breathing: as clinic practice, we use it as part of holistic care for stress and metabolic health. We found no trial of it in metabolic syndrome; its trials are mainly in asthma (Cochrane review, 2020) [36], and a 2023 meta-analysis linked breathwork in general with lower self-reported stress [37].

Do supplements help metabolic syndrome? Magnesium, vitamin D, omega-3 and berberine

No supplement replaces diet and exercise: in a 2025 meta-analysis of 25 trials, vitamin D did not significantly change blood fats, blood sugar or waist size [8], and the evidence for other supplements is mixed. We use supplements to correct deficiencies and, where markers stay high, as support under supervision, within official limits.

• Vitamin D: in most cases we correct low levels with standard supplement doses; the upper limit for adults is 4,000 IU a day, according to the US National Institutes of Health [38]. Because trials did not show that vitamin D changes blood fats, blood sugar or waist size [8], we use it to correct a deficiency, not as a treatment for the syndrome. If you also have an autoimmune condition, your vitamin D plan follows that condition.
• Magnesium: the upper limit from supplements is 350 mg of elemental magnesium a day for adults, and absorption varies by form, according to the US National Institutes of Health [11].
• Omega-3 for triglycerides: the American Heart Association found that 4 g a day of prescription omega-3 lowers triglycerides of 200 to 499 mg/dL by about 20% to 30%, and that over-the-counter fish oil supplements are not approved substitutes for prescription products [39].
• Omega-3 safety: the US FDA and the European Food Safety Authority consider up to 5 g a day of EPA and DHA from supplements safe, but 4 g a day for several years slightly raised the risk of atrial fibrillation in people with heart disease, according to the US National Institutes of Health [40].
• Berberine: in a 2025 meta-analysis of 12 placebo-controlled trials (889 people, mostly in China, only 2 rated high quality), berberine lowered triglycerides, fasting blood sugar and waist (by about 3 cm), with no effect on HDL or blood pressure; reported side effects included low blood sugar, nausea and constipation [41].
• Berberine safety: goldenseal, a herb that contains berberine, can change how the body processes many medicines, lowered metformin levels by about 25% in one study, and should not be used in pregnancy or breastfeeding, according to the US National Center for Complementary and Integrative Health [42].
• At Cure4Pain: where triglycerides or blood sugar markers stay high, we may add omega-3 or berberine under supervision. This is clinic practice; individual results vary, and further studies are needed. Please do not start berberine on your own if you take diabetes or other medicines.
• Digestion and bile flow: as clinic practice, some people are given supplements that support digestive and bile acids; we found no trial of these in metabolic syndrome.

How are fatty liver (MASLD) and high triglycerides managed?

Fatty liver is checked for liver scarring first: the AASLD advises a simple blood-based score (FIB-4) for everyone with fatty liver, followed by a liver stiffness test (elastography) if the score is 1.3 or higher, and referral to a liver specialist when advanced scarring is suspected [29].

• Weight loss: the AASLD notes that losing 3% to 5% of body weight improves liver fat, while more than 10% is generally needed to improve liver inflammation and scarring [29].
• At Cure4Pain: we assess fatty liver with blood tests and a liver ultrasound or liver stiffness scan, and manage it with the same diet, exercise and nutrient plan, adding supplements or medicines where needed. Where tests suggest liver scarring, Dr Krushal Pabari involves a liver specialist (hepatologist).
• High triglycerides: the same plan, with omega-3 or berberine where triglycerides stay high (see the supplements section).

How is insulin resistance in PCOS managed?

Women with PCOS have about 3.4 times the odds of metabolic syndrome, mainly linked with body weight, according to a 2019 meta-analysis in Obesity Reviews [19], so we manage the insulin resistance and metabolic side of PCOS with the same diet, exercise and nutrient plan.

• Inositol: we sometimes use inositol. A 2024 meta-analysis of 30 trials (2,230 women), carried out for the 2023 International PCOS Guideline, found some benefit for metabolic measures but called the evidence limited and inconclusive; myo-inositol caused fewer stomach side effects than metformin [43][44]. This is clinic practice; individual results vary, and further studies are needed.
• Pregnancy: we refer pregnant women to their obstetrician.

What medicines are used for metabolic syndrome? Statins, blood pressure, metformin and GLP-1 medicines

Many people with metabolic syndrome take medicines for cholesterol, blood pressure or blood sugar; the NHS says medicines may be offered for weight loss, insulin resistance, cholesterol or blood pressure alongside lifestyle changes [14].

• Statins: the NHS says statins are usually taken long term, including by people who already have cardiovascular disease, to lower the risk of a heart attack or stroke, and advises talking to a doctor or pharmacist before stopping them [45].
• Metformin: in the Diabetes Prevention Program, metformin lowered new cases of metabolic syndrome by 17% [18].
• At Cure4Pain: Dr Krushal Pabari reviews statins, blood-pressure medicines and metformin and, depending on the case, may reduce them gradually after blood markers have improved for a sustained period, under clinical guidance from Team Cure4Pain. For people who have had a heart attack or stroke, statin decisions are made together with their cardiologist. Do not stop any medicine without medical guidance.
• GLP-1 medicines: in the STEP 1 trial, weekly semaglutide with lifestyle change lowered body weight by 14.9% over 68 weeks, compared with 2.4% with placebo; nausea and diarrhoea were the most common side effects [46].
• Heart outcomes: in the SELECT trial of 17,604 people with heart disease and overweight but no diabetes, heart attacks, strokes and cardiovascular deaths occurred in 6.5% with semaglutide and 8.0% with placebo, and 16.6% stopped the medicine because of side effects, compared with 8.2% on placebo [47].
• After stopping: one year after stopping semaglutide, people in the STEP 1 extension had regained about two-thirds of the weight they had lost [48].
• Our approach to GLP-1 medicines: Cure4Pain does not usually prescribe GLP-1 weight-loss medicines; we consider them only where clearly needed, in coordination with your physician. If you already take one, we work alongside it.

How long does metabolic syndrome take to improve?

Many people notice meaningful changes in waist size, triglycerides and blood sugar markers within about 3 months. This is a clinic observation; individual results vary, and further studies are needed. We repeat blood tests every 3 months, and monitoring continues for life.

• What the research shows: in the low-carbohydrate feeding study, changes were seen within 4 weeks [24], and in the 10-hour eating study within 12 weeks [28].

Can metabolic syndrome go away? Meeting fewer than 3 criteria

Yes, a person can stop meeting the criteria: when fewer than 3 of the 5 findings remain, a person no longer meets the criteria for metabolic syndrome [1], as 9 of 16 people did after 4 weeks of a low-carbohydrate diet in one small study [24].

• Monitoring continues: the underlying tendency stays, so diet, exercise and blood tests every 3 months continue. In our clinical experience, stopping them often brings the findings back; this is an observation, not a trial result, individual results vary, and further studies are needed.

When should I get urgent help?

Metabolic syndrome itself is not an emergency, but its effects can be: call emergency services if you have chest pain that spreads to your arms, neck, jaw, stomach or back, or chest pain with sweating, feeling sick, light-headedness or breathlessness, because it could be a heart attack, according to the NHS [49]. Also call for signs of a stroke: one side of the face drooping, being unable to lift both arms, or slurred or confused speech (the NHS FAST signs) [50]. Call 112 in India, 911 in the US or 999 in the UK. Cure4Pain does not treat sudden or severe pain.

Does Cure4Pain work with my own doctor?

Yes. We work alongside your existing consulting physician, cardiologist, diabetologist or liver specialist, share our findings with them, and any change to medicines is made under clinical guidance from Team Cure4Pain, in coordination with them.

What happens at a metabolic syndrome consultation?

After your tests, your first consultation (in Mumbai or online) covers your history, waist and body composition, diet, activity, sleep, medicines and test results. You then receive a written plan for diet and meal timing, exercise, nutrients and medicine review. We see adults and young people aged 16 and over. Follow-up reviews with blood tests are planned every 3 months. Individual results vary.

Evidence: key studies

Who treats you

• Dr Krushal PabariMD, PGCP - Rheumatic & Musculoskeletal Diseases. Assistant Professor, Cooper Hospital; Guest Professor, CMP Homoeopathic Medical College.
• AT. Chintan Dalal, N.D.BNYS, R.AP. Functional nutrition and Coimbra Protocol practitioner.

Consultations look at the whole person: alongside the medical and nutritional plan, we bring a strong interest in behavioural science to counselling on stress, sleep and lasting lifestyle change.

How consultations work: Mumbai or online worldwide

Book through our patient portal. You can see us in person at our clinic in Malad West, Mumbai, or online from anywhere. Your first consultation reviews your history and tests; we then agree a plan together and set the monitoring schedule.

Related conditions and articles

• Type 2 DiabetesInsulin resistance, low-carb Indian diet, strength training and diabetes care.
• Hypothyroidism (Underactive Thyroid)Underactive thyroid; vitamin D, B12, iron, diet and thyroid care.
• Insomnia & Sleep ProblemsTrouble falling or staying asleep; vitamin D, nutrition, breathing and sleep habits.
• Gut Dysbiosis & Gut HealthImbalance of gut bacteria: bloating, bowel changes, SIBO and the gut and immune link.

• Lifestyle and metabolic conditions
• Type 2 diabetes

This page is for education and does not replace medical advice. Do not start, stop or change any medicine or supplement without medical guidance.

References

1. Alberti KG, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120(16):1640-5. doi:10.1161/CIRCULATIONAHA.109.192644

2. Mottillo S, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010;56(14):1113-32. doi:10.1016/j.jacc.2010.05.034

3. Krishnamoorthy Y, et al. Prevalence of metabolic syndrome among adult population in India: A systematic review and meta-analysis. PLoS One 2020;15(10):e0240971. doi:10.1371/journal.pone.0240971

4. Noubiap JJ, et al. Geographic distribution of metabolic syndrome and its components in the general adult population: A meta-analysis of global data from 28 million individuals. Diabetes Res Clin Pract 2022;188:109924. doi:10.1016/j.diabres.2022.109924

5. Kim Y, Je Y. Intake or Blood Levels of Magnesium and Risk of Metabolic Syndrome: A Meta-Analysis of Observational Studies. Nutrients 2025;17(10). doi:10.3390/nu17101667

6. Dibaba DT, et al. Dietary magnesium intake and risk of metabolic syndrome: a meta-analysis. Diabet Med 2014;31(11):1301-9. doi:10.1111/dme.12537

7. Ju SY, et al. Blood vitamin D status and metabolic syndrome in the general adult population: a dose-response meta-analysis. J Clin Endocrinol Metab 2014;99(3):1053-63. doi:10.1210/jc.2013-3577

8. Ge L, et al. Effect of vitamin D supplementation on body composition, lipid profile, and glycemic indices in patients with obesity-associated metabolic syndrome: a systematic review and meta-analysis. Diabetol Metab Syndr 2025;17(1):287. doi:10.1186/s13098-025-01799-1

9. Oliveira INN, et al. Effects of vitamin D supplementation on metabolic syndrome parameters in patients with obesity or diabetes in Brazil, Europe, and the United States: A systematic review and meta-analysis. J Steroid Biochem Mol Biol 2024;243:106582. doi:10.1016/j.jsbmb.2024.106582

10. Pittas AG, et al. Vitamin D Supplementation and Prevention of Type 2 Diabetes. N Engl J Med 2019;381(6):520-530. doi:10.1056/NEJMoa1900906

11. Office of Dietary Supplements, US National Institutes of Health. Magnesium: Fact Sheet for Health Professionals. ods.od.nih.gov/factsheets/Magnesium-HealthProfessional

12. Misra A, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India 2009;57:163-70. pubmed.ncbi.nlm.nih.gov/19582986

13. National Heart, Lung, and Blood Institute (NHLBI), US National Institutes of Health. What Is Metabolic Syndrome? nhlbi.nih.gov/health/metabolic-syndrome

14. NHS. Metabolic syndrome. nhs.uk/conditions/metabolic-syndrome

15. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), US National Institutes of Health. Insulin Resistance & Prediabetes. niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/prediabetes-insulin-resistance

16. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363(9403):157-63. doi:10.1016/S0140-6736%2803%2915268-3

17. Chen Z, et al. Ultra-Processed Food Consumption and Risk of Type 2 Diabetes: Three Large Prospective U.S. Cohort Studies. Diabetes Care 2023;46(7):1335-1344. doi:10.2337/dc22-1993

18. Orchard TJ, et al. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 2005;142(8):611-9. doi:10.7326/0003-4819-142-8-200504190-00009

19. Lim SS, et al. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obes Rev 2019;20(2):339-352. doi:10.1111/obr.12762

20. Rinella ME, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 2023;78(6):1966-1986. doi:10.1097/HEP.0000000000000520

21. Yuan H, et al. Serum Uric Acid Levels and Risk of Metabolic Syndrome: A Dose-Response Meta-Analysis of Prospective Studies. J Clin Endocrinol Metab 2015;100(11):4198-207. doi:10.1210/jc.2015-2527

22. National Heart, Lung, and Blood Institute (NHLBI), US National Institutes of Health. Metabolic Syndrome: Diagnosis. nhlbi.nih.gov/health/metabolic-syndrome/diagnosis

23. NHS. Cushing’s syndrome. nhs.uk/conditions/cushings-syndrome

24. Hyde PN, et al. Dietary carbohydrate restriction improves metabolic syndrome independent of weight loss. JCI Insight 2019;4(12). doi:10.1172/jci.insight.128308

25. Kastorini CM, et al. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol 2011;57(11):1299-313. doi:10.1016/j.jacc.2010.09.073

26. Anitha S, et al. A Systematic Review and Meta-Analysis of the Potential of Millets for Managing and Reducing the Risk of Developing Diabetes Mellitus. Front Nutr 2021;8:687428. doi:10.3389/fnut.2021.687428

27. Muraki I, et al. Fruit consumption and risk of type 2 diabetes: results from three prospective longitudinal cohort studies. BMJ 2013;347:f5001. doi:10.1136/bmj.f5001

28. Wilkinson MJ, et al. Ten-Hour Time-Restricted Eating Reduces Weight, Blood Pressure, and Atherogenic Lipids in Patients with Metabolic Syndrome. Cell Metab 2020;31(1):92-104.e5. doi:10.1016/j.cmet.2019.11.004

29. Rinella ME, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 2023;77(5):1797-1835. doi:10.1097/HEP.0000000000000323

30. Poon ET, et al. Efficacy of Exercise-Based Interventions for Metabolic Syndrome: An Umbrella Review With Meta-Analyses. Obes Rev 2026;27(11):e70144. doi:10.1111/obr.70144

31. Poon ET, et al. High-intensity interval training for cardiometabolic health in adults with metabolic syndrome: a systematic review and meta-analysis of randomised controlled trials. Br J Sports Med 2024;58(21):1267-1284. doi:10.1136/bjsports-2024-108481

32. Wewege MA, et al. Aerobic, resistance or combined training: A systematic review and meta-analysis of exercise to reduce cardiovascular risk in adults with metabolic syndrome. Atherosclerosis 2018;274:162-171. doi:10.1016/j.atherosclerosis.2018.05.002

33. Srikanthan P, Karlamangla AS. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab 2011;96(9):2898-903. doi:10.1210/jc.2011-0435

34. Ding D, et al. Daily steps and health outcomes in adults: a systematic review and dose-response meta-analysis. Lancet Public Health 2025;10(8):e668-e681. doi:10.1016/S2468-2667%2825%2900164-1

35. Cramer H, et al. Yoga for metabolic syndrome: A systematic review and meta-analysis. Eur J Prev Cardiol 2016;23(18):1982-1993. doi:10.1177/2047487316665729

36. Santino TA, et al. Breathing exercises for adults with asthma. Cochrane Database Syst Rev 2020;3(3):CD001277. doi:10.1002/14651858.CD001277.pub4

37. Fincham GW, et al. Effect of breathwork on stress and mental health: A meta-analysis of randomised-controlled trials. Sci Rep 2023;13(1):432. doi:10.1038/s41598-022-27247-y

38. Office of Dietary Supplements, US National Institutes of Health. Vitamin D: Fact Sheet for Health Professionals. ods.od.nih.gov/factsheets/VitaminD-HealthProfessional

39. Skulas-Ray AC, et al. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association. Circulation 2019;140(12):e673-e691. doi:10.1161/CIR.0000000000000709

40. Office of Dietary Supplements, US National Institutes of Health. Omega-3 Fatty Acids: Fact Sheet for Health Professionals. ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional

41. Liu D, et al. Efficacy and safety of berberine on the components of metabolic syndrome: a systematic review and meta-analysis of randomized placebo-controlled trials. Front Pharmacol 2025;16:1572197. doi:10.3389/fphar.2025.1572197

42. National Center for Complementary and Integrative Health (NCCIH), US National Institutes of Health. Goldenseal: Usefulness and Safety. nccih.nih.gov/health/goldenseal

43. Fitz V, et al. Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines. J Clin Endocrinol Metab 2024;109(6):1630-1655. doi:10.1210/clinem/dgad762

44. Teede HJ, et al. Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. J Clin Endocrinol Metab 2023;108(10):2447-2469. doi:10.1210/clinem/dgad463

45. NHS. Statins. nhs.uk/medicines/statins

46. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183

47. Lincoff AM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med 2023;389(24):2221-2232. doi:10.1056/NEJMoa2307563

48. Wilding JPH, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes Obes Metab 2022;24(8):1553-1564. doi:10.1111/dom.14725

49. NHS. Chest pain. nhs.uk/symptoms/chest-pain

50. NHS. Symptoms of a stroke. nhs.uk/conditions/stroke/symptoms